Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
20 Febrero 2024 - 3:05PM
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology
company pioneering immuno-neurology, today announced it will host a
conference call and webcast on Tuesday, February 27, 2024, at 4:30
p.m. ET to discuss results for the fourth quarter ended December
31, 2023, and provide a full-year business update. A press release
detailing fourth quarter results will be issued prior to the call.
The event will be webcast live under the investor relations
section of Alector’s website at
https://investors.alector.com/events-and-presentations/events and
following the event a replay will be archived there for 30 days.
Interested parties participating by phone will need to register
using this online form. After registering for dial-in details, all
phone participants will receive an auto-generated e-mail containing
a link to the dial-in number along with a personal PIN number to
use to access the event by phone.
About AlectorAlector is a clinical-stage
biotechnology company pioneering immuno-neurology, a novel
therapeutic approach for the treatment of neurodegenerative
diseases. Immuno-neurology targets immune dysfunction as a root
cause of multiple pathologies that are drivers of degenerative
brain disorders. Alector has discovered and is developing a broad
portfolio of innate immune system programs, designed to
functionally repair genetic mutations that cause dysfunction of the
brain’s immune system and enable rejuvenated immune cells to
counteract emerging brain pathologies. Alector’s immuno-neurology
product candidates are supported by biomarkers and seek to treat
indications, including Alzheimer’s disease and genetically defined
frontotemporal dementia patient populations. Alector is
headquartered in South San Francisco, California.
Alector Contacts: AlectorKatie
Hogan202-549-0557katie.hogan@alector.com
1AB (media) Dan Budwick 973-271-6085 dan@1abmedia.com
Argot Partners (investors)Laura
Perry212.600.1902alector@argotpartners.com
Alector (NASDAQ:ALEC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Alector (NASDAQ:ALEC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024